BriefHealth
CNBC's Julia Boorstin joins 'The Exchange' to discuss what to expect from Meta's Connect.
C
Read full storyCnbc
Original source
Trending
Someone else's Apple Watch might start spying on your conversationsGoogle's data-devouring AI wants everyone's personal informationMamdani blasts DoorDash CEO's 'greedy algorithm,' NY slaps company with $131 million fineUS veteran teamed up with former enemy colonel decades after fighting in Vietnam war. Their mission was to remove bombsBJP Reopens Sonia Gandhi's 1980 'Vote Story' Amid S.I.R Row; Deflection Or 'Vote Chori' Tide Turns?Ram Mandir Donation Case: CNN-News18 Accesses Exclusive Details Of Evidence Against 8 AccusedUP legislative council polls for 11 graduate, teacher seats on Oct 23Checked shirt, jeans, stubble: Teen’s description led cops to Delhi gangrape accusedSomeone else's Apple Watch might start spying on your conversationsGoogle's data-devouring AI wants everyone's personal informationMamdani blasts DoorDash CEO's 'greedy algorithm,' NY slaps company with $131 million fineUS veteran teamed up with former enemy colonel decades after fighting in Vietnam war. Their mission was to remove bombsBJP Reopens Sonia Gandhi's 1980 'Vote Story' Amid S.I.R Row; Deflection Or 'Vote Chori' Tide Turns?Ram Mandir Donation Case: CNN-News18 Accesses Exclusive Details Of Evidence Against 8 AccusedUP legislative council polls for 11 graduate, teacher seats on Oct 23Checked shirt, jeans, stubble: Teen’s description led cops to Delhi gangrape accused
Related Stories
Health8h ago
Envisagenics and Boehringer Ingelheim Enter Multi-Target Collaboration to Develop First-in-Class Precision Therapies Based on RNA Splicing-Derived Targets for Hard-to
NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Envisagenics today announced a multi-year research collaboration and option agreement with Boehringer Ingelheim to validate selected tumor-specific targets for the development of first-in-class precision therapies for people living with solid tumors. Envisagenics has pioneered an artificial intelligence (AI)-powered approach that is transforming alternative RNA splicing into a new frontier for drug discovery.
GGlobe Newswire
Health8h ago
Adventist Health Bakersfield Introduces Kern County’s First Next Generation Robotic
Adventist Health Bakersfield is first in Kern County to use Noah Medical's next-generation, robotic-assisted bronchoscopy for earlier lung cancer diagnosis
GGlobe Newswire
Health2h ago
Plan to cut 400 jobs at Hamilton Health Sciences will increase wait times, further erode morale: union
The union representing employees at Hamilton Health Sciences says a plan to cut more than 400 jobs will result in “overcrowded hospitals” and “unsafe conditions for patients and workers.”
CCtv News
Health2h ago
Binghamton University scientists win seed funding for medical technologies
Two Binghamton University faculty members will receive seed funding through the State University of New York (SUNY) Technology Accelerator Fund (TAF), which provides grants to faculty inventors and scientists.
MMedical News